← Return to Was your endometrial cancer tested for mutations in the gene POLE?

Discussion
Comment receiving replies
@val64

Many thanks for responding so quickly and for the info. Was this at Mayo?

I'm interested in it for the prognostic value. (I do not have colorectal cancer in my family.) I will feel quite differently about further treatment depending on the result.

I also think it is a reasonable thing to want because the most recent version of the NCCN Guidelines for endometrial carcinoma recommends molecular classification based on 3 tests: POLE sequencing, immunohistochemistry (IHC) for mismatch repair (MMR) proteins, and IHC for p53 (ENDO-A p. 3 of 4). This is based on a number of publications over the last few years that categorize endometrial carcinomas into 4 groups: 1) POLE mutants (from sequencing), 2) mismatch repair defective (from MMR IHC), 3) copy number high (from p53 IHC), and 4) copy number low (everything else). POLE mutants have a very good prognosis, while copy number high have the worst prognosis, and includes some high grade endometriod carcinomas as well as serous carcinomas.

Many POLE mutant cancers are like mine, presenting with high grade and greater depth of myometrial invasion. But some copy number high cancers are also like mine. I will feel quite differently about how aggressively my cancer should be treated if it's POLE mutant vs. copy number high. (IHC for MMR and p53 have been done on my specimen.) Once I'm given a treatment plan from my current team (hopefully soon), I'll have to decide whether to go looking for a second opinion, and whether I'll have to make access to a POLE test a criteria for where.

Jump to this post


Replies to "Many thanks for responding so quickly and for the info. Was this at Mayo? I'm interested..."

Hello NatureGirl15,
I am recently diagnosed with endometrial carcinoma 1B Grade 3. I had a total hysterectomy 2 weeks ago and await pelvic radiation therapy (28 doses).

Kindly post the link to the link to the NCCN Guidelines for endometrial carcinoma recommendation of molecular classification based on 3 tests. I would like to pursue this further with my physicians.

Wishing you all the very best.